» Authors » Hamid Echchakir

Hamid Echchakir

Explore the profile of Hamid Echchakir including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 176
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hacein-Bey-Abina S, Estienne M, Bessoles S, Echchakir H, Pederzoli-Ribeil M, Chiron A, et al.
Exp Hematol . 2020 Jul; 88:15-27. PMID: 32721504
Thrombopoietin (TPO), through activation of its cognate receptor Mpl, is the major regulator of platelet production. However, residual platelets observed in TPO- and Mpl-loss-of-function (LOF) mice suggest the existence of...
2.
Vidalin O, Muslmani M, Estienne C, Echchakir H, Abina A
Curr Opin Pharmacol . 2009 Aug; 9(5):669-76. PMID: 19646923
Most diseases have multifactorial origins and their study requires complex in vivo validation strategies selected for their particular relevance. Most of the in vivo models used to date have been...
3.
El Hage F, Stroobant V, Vergnon I, Baurain J, Echchakir H, Lazar V, et al.
Proc Natl Acad Sci U S A . 2008 Jul; 105(29):10119-24. PMID: 18626012
We identified an antigen recognized on a human non-small-cell lung carcinoma by a cytotoxic T lymphocyte clone derived from autologous tumor-infiltrating lymphocytes. The antigenic peptide is presented by HLA-A2 and...
4.
Poszepczynska-Guigne E, Schiavon V, DIncan M, Echchakir H, Musette P, Ortonne N, et al.
J Invest Dermatol . 2004 Apr; 122(3):820-3. PMID: 15086570
CD158k molecules belong to the family of killer cell immunoglobulin-like receptors (KIR) that are expressed on a minor population of circulating NK and CD8+ T lymphocytes. Here, we report a...
5.
Dorothee G, Echchakir H, Le Maux Chansac B, Vergnon I, El Hage F, Moretta A, et al.
Oncogene . 2003 Oct; 22(46):7192-8. PMID: 14562047
T lymphocytes infiltrating a human lung carcinoma stimulated in vitro with autologous tumor cell line showed a TCRVbeta13.6(+) T-cell expansion. This subset was isolated using TCRVbeta-specific antibody and several T-cell...
6.
Dangles-Marie V, Richon S, El-Behi M, Echchakir H, Dorothee G, Thiery J, et al.
Cancer Res . 2003 Jul; 63(13):3682-7. PMID: 12839959
We described previously a CTL clone able to lyse the autologous carcinoma cell line IGR-Heu after specific recognition of an HLA-A2/mutated alpha-actinin-4 peptide complex. Here, we used IGR-Heu, cultured either...
7.
Thiery J, Dorothee G, Haddada H, Echchakir H, Richon C, Stancou R, et al.
J Immunol . 2003 Jun; 170(12):5919-26. PMID: 12794118
Inactivation of p53 has been implicated in many types of tumors particularly in non-small cell lung carcinoma, one of the most common cancers in which p53 mutation has been frequently...
8.
Mami-Chouaib F, Echchakir H, Dorothee G, Vergnon I, Chouaib S
Immunol Rev . 2002 Nov; 188:114-21. PMID: 12445285
We have isolated several cytotoxic T lymphocyte (CTL) clones from lymphocytes infiltrating a lung carcinoma of a patient with long survival. These clones showed a CD3+, CD8+, CD4-, CD28- phenotype...
9.
Dorothee G, Vergnon I, Menez J, Echchakir H, Grunenwald D, Kubin M, et al.
J Immunol . 2002 Jul; 169(2):809-17. PMID: 12097384
In the present report, we have investigated TRAIL/APO2 ligand (APO2L) expression, regulation, and function in human lung carcinoma tumor-infiltrating lymphocytes. Using a panel of non-small cell lung carcinoma cell lines,...
10.
Echchakir H, Dorothee G, Vergnon I, Menez J, Chouaib S, Mami-Chouaib F
Proc Natl Acad Sci U S A . 2002 Jul; 99(14):9358-63. PMID: 12093915
We have previously identified an antigen (Ag) recognized on a human large cell carcinoma of the lung by a tumor-specific cytotoxic T lymphocyte clone derived from autologous tumor infiltrating lymphocytes...